C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction. Leicester Acute Myocardial Infarction Peptide (LAMP) Study

American Heart Journal

Volumn 154, Issue 4, 2007, Pages 736-742

  Khan, Sohail Q ^a   Dhillon, Onkar ^a   Struck, Joachim ^b   Quinn, Paulene ^a   Morgenthaler, Nils G ^b   Squire, Ian B ^a   Davies, Joan E ^a   Bergmann, Andreas ^b   Ng, Leong L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENDOTHELIN 1;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIAC PATIENT; DEATH; DISEASE MARKER; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; SURVIVAL RATE; THORAX PAIN;

AGED; COMORBIDITY; ENDOTHELIN-1; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; RISK ASSESSMENT; ROC CURVE; SURVIVAL ANALYSIS;

EID: 34548706632     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.016     Document Type: Article

References (23)

1. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
2. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
3. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
4. Inoue A., Yanagisawa M., Kimura S., et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86 (1989) 2863-2867
5. Haynes W.G., Strachan F.E., and Webb D.J. Endothelin ET(A) and ET(B) receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92 (1995) 357-363
6. Rossi G.P., Seccia T.M., Albertin G., et al. Measurement of endothelin: clinical and research use. Ann Clin Biochem 37 (2000) 608-626
7. Brunner F., Stessel H., Watzinger N., et al. Binding of endothelin to plasma proteins and tissue receptors: effects on endothelin determination, vasoactivity, and tissue kinetics. FEBS Lett 373 (1995) 97-101
8. Papassotiriou J., Morgenthaler N.G., Struck J., et al. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem 52 (2006) 1144-1151
9. Struck J., Morgenthaler N.G., and Bergmann A. Proteolytic processing pattern of the endothelin-1 precursor in vivo. Peptides 26 (2005) 2482-2486
10. Kiely D.G., Cargill R.I., Struthers A.D., et al. Cardiopulmonary effects of endothelin-1 in man. Cardiovasc Res 33 (1997) 378-386
11. Wei C.M., Lerman A., Rodeheffer R.J., et al. Endothelin in human congestive heart failure. Circulation 89 (1994) 1580-1586
12. Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 125 (1993) 667-672
13. Wieczorek I., Haynes W.G., Webb D.J., et al. Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J 72 (1994) 436-441
14. Omland T., Lie R.T., Aakvaag A., et al. Plasma endothelin determination as a prognostic indicator of one year after acute myocardial infarction. Circulation 89 (1994) 1573-1579
15. Omland T., de Lemos J.A., Morrow D.A., et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 89 (2002) 463-465
16. Squire I.B., O'Brien R.J., Demme B., et al. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci (Lond) 107 (2004) 309-316
17. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
18. Smilde T.D., van Veldhuisen D.J., Navis G., et al. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114 (2006) 572-580
19. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
20. Stewart D.J., Kubac G., Costello K.B., et al. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18 (1991) 38-43
21. Cernacek P., and Stewart D.J. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 161 (1989) 562-567
22. Kurihara H., Yamaoki K., Nagai R., et al. Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life Sci 44 (1989) 1937-1943
23. Grover G.J., Dzwonczyk S., and Parham C.S. The endothelin-1 receptor antagonist BQ-123 reduced infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 27 (1993) 1613-1618